HER2 EXON 20 MUTATION

Clinical trials for HER2 EXON 20 MUTATION explained in plain language.

Never miss a new study

Get alerted when new HER2 EXON 20 MUTATION trials appear

Sign up with your email to follow new studies for HER2 EXON 20 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill challenges chemo for Tough-to-Treat lung cancer

Disease control Completed

This study tested whether a daily pill called pyrotinib works better than standard chemotherapy (docetaxel) for people with advanced non-squamous lung cancer that has a specific HER2 gene mutation and has worsened after initial platinum-based chemotherapy. It involved 151 partici…

Matched conditions: HER2 EXON 20 MUTATION

Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HER2 EXON 20 MUTATION

Get alerted when new HER2 EXON 20 MUTATION trials appear

New pill challenges chemo for Tough-to-Treat lung cancer